首页> 外文OA文献 >Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study

【2h】

Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study

机译：在临床实践中接受贝利木单抗的系统性红斑狼疮患者的贝利木单抗使用，临床结局和糖皮质激素减少：OBSErve Canada研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study [J] . Touma Zahi, Sayani Amyn, Pineau Christian A., Rheumatology international. . 2017,第6期

机译：Belimumab使用，临床结果和糖皮质激素减少，患有Systemic Lupus红斑狼疮，在临床实践环境中接受Belimalab：由加拿大观察研究结果
2. Disease Severity and Glucocorticoids Reduction in Systemic Lupus Erythematosus (SLE) Patients Receiving Belimumab in Clinical Practice Settings: Results from OBSErve Study in Canada [J] . Touma Zahi, Sayani Amyn, Iczkovitz Sandra The Journal of rheumatology . 2016,第6期

机译：在临床实践中接受贝利木单抗的系统性红斑狼疮（SLE）患者的疾病严重程度和糖皮质激素减少：加拿大OBSErve研究的结果
3. Disease Severity and Glucocorticoids Reduction in Systemic Lupus Erythematosus (SLE) Patients Receiving Belimumab in Clinical Practice Settings: Results from OBSErve Study in Canada [J] . Touma Zahi, Sayani Amyn, Iczkovitz Sandra The Journal of rheumatology . 2016,第6期

机译：疾病严重程度和糖皮质激素减少全身性狼疮（SLE）临床实践环境中的Belimalab患者：在加拿大观察研究结果
4. Effects of glucocorticoids on expression of CD4+ Foxp3+ T cell in patients with systemic lupus erythematosus [C] . Sheng-nan Zhao, Ya-yi Hou, Ling-yun Sun International Forum on Progress on Post-Genome Technologies(5'IFPT); 20070910-11; Suzhou(CN) . 2007

机译：糖皮质激素对系统性红斑狼疮患者CD4 + Foxp3 + T细胞表达的影响
5. Acquired Low Immunoglobulin Levels and Risk of Clinically Relevant Infection in Adult Patients with Systemic Lupus Erythematosus Cohort Study [D] . Almaghlouth, Ibrahim Ali S. 2019

机译：在成人狼疮患者中获得低免疫球蛋白水平和临床相关感染的风险红斑狼疮队列队列研究
6. Belimumab use clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study [O] . Zahi Touma, Amyn Sayani, Christian A. Pineau, -1

机译：在临床实践中接受贝利木单抗的系统性红斑狼疮患者的贝利木单抗使用临床结局和糖皮质激素减少：OBSErve Canada研究的结果
7. First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study [O] . 2016

机译：在德国对系统性红斑狼疮的常规临床护理中贝利木单抗的使用和结果的首次真实观察：来自OBSErve Germany研究的结果

Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study

著录项

引文网络

相似文献

相关主题

期刊订阅